Screener
Sarepta Therapeutics, Inc. SRPT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Other current assets | 105,784 | 171,856 |
| Total current assets | 2,223,824 | 2,537,938 |
| Property and equipment, net | 325,991 | 345,125 |
| Right of use assets | 120,847 | 125,495 |
| Non-current inventory | 226,333 | 184,543 |
| Non-current investments | 145,372 | 1,048 |
| Other non-current assets | 146,145 | 155,554 |
| Total assets | $3,188,512 | $3,349,703 |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s operating lease ROU assets?
- Sarepta Therapeutics, Inc. (SRPT) reported operating lease ROU assets of $120.85M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Sarepta Therapeutics, Inc.'s operating lease ROU assets decreased by 15.5% year-over-year, from $143.04M to $120.85M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s operating lease ROU assets has grown at a 6.5% compound annual growth rate (CAGR), from $91.76M to $125.5M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Sarepta Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude